Nikhil Raj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nikhil Raj has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Jyotsna Agarwal
Department of Microbiology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
3 shared publications - Vikramjeet Singh
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow
2 shared publications Anupam Das
1–5Department of Microbiology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
1 shared publication- Anupam Das
Department of Microbiology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
1 shared publication - Apurva Rautela
1–4,6Department of Microbiology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
1 shared publication Ashish Verma
1–4,6Department of Microbiology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
1 shared publication
Latest Publications
- Open Access
- 31 May 2026
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 20 (05) , 687-692
Direct MALDI-TOF MS identification from positive blood culture bottles: a time-saving approach to reduce diagnostic delays
Introduction: Bloodstream infections are a leading cause of mortality worldwide, necessitating prompt identification and treatment to improve patient outcomes. Conventional methods are time-consuming, often delaying appropriate antimicrobial therapy. Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has emerged as a revolutionary tool for rapid microbial identification. This study aimed to evaluate the utility of direct microbial identification from positive blood cultures using MALDI-TOF MS in reducing diagnostic delays and improving pathogen detection for effective clinical management. Methodology: This prospective study analyzed 416 monomicrobial positive blood cultures obtained between October 2022 and October 2024 from a tertiary care teaching hospital in North India. After Gram staining and initial processing, direct microbial identification was performed using MALDI-TOF MS. Conventional subculture-based methods were employed as the gold standard for comparison. Results: Of the 416 isolates, 89% were correctly identified at the species level using the direct method. Among 204 Gram positive cocci, 91.6% were correctly identified, with species-specific rates of 100% for Staphylococcus aureus and Staphylococcus ureilyticus. Out of 160 Gram negative bacilli, 88.1% were accurately identified, with Acinetobacter baumannii showing 97.5% accuracy. Candida species showed a correct identification rate of 80.8%, with 100% identification for Candida albicans and Candida krusei. Conclusions: Direct microbial identification using MALDI-TOF MS is a rapid, cost-effective alternative to conventional methods, enabling faster pathogen detection and supporting antimicrobial stewardship.
- 31 May 2026
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 20 (05) , 687-692
Open AccessDirect MALDI-TOF MS identification from positive blood culture bottles: a time-saving approach to reduce diagnostic delays
Introduction: Bloodstream infections are a leading cause of mortality worldwide, necessitating prompt identification and treatment to improve patient outcomes. Conventional methods are time-consuming, often delaying appropriate antimicrobial therapy. Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has emerged as a revolutionary tool for rapid microbial identification. This study aimed to evaluate the utility of direct microbial identification from positive blood cultures using MALDI-TOF MS in reducing diagnostic delays and improving pathogen detection for effective clinical management. Methodology: This prospective study analyzed 416 monomicrobial positive blood cultures obtained between October 2022 and October 2024 from a tertiary care teaching hospital in North India. After Gram staining and initial processing, direct microbial identification was performed using MALDI-TOF MS. Conventional subculture-based methods were employed as the gold standard for comparison. Results: Of the 416 isolates, 89% were correctly identified at the species level using the direct method. Among 204 Gram positive cocci, 91.6% were correctly identified, with species-specific rates of 100% for Staphylococcus aureus and Staphylococcus ureilyticus. Out of 160 Gram negative bacilli, 88.1% were accurately identified, with Acinetobacter baumannii showing 97.5% accuracy. Candida species showed a correct identification rate of 80.8%, with 100% identification for Candida albicans and Candida krusei. Conclusions: Direct microbial identification using MALDI-TOF MS is a rapid, cost-effective alternative to conventional methods, enabling faster pathogen detection and supporting antimicrobial stewardship.
- Open Access
- 27 December 2024
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 14 (2) , 176-181
Clinicoepidemiology and Diagnosis of Hepatitis C: Evaluating HCV Core Antigen Assay as a Diagnostic Tool in a Tertiary Care Teaching Hospital of North India
One of the main causes of primary hepatocellular carcinoma and chronic hepatitis is the hepatitis C virus (HCV), with significant variability in its genotypes affecting pathogenicity and treatment outcomes. In India, prevalence ranges from 0.5 to 1.5%, with certain regions showing higher rates. Diagnostic methods include serological and molecular assays, with the HCV core antigen (HCV cAg) assay emerging as a cost-effective substitute for HCV RT-PCR testing. This study enrolled 292 suspected hepatitis cases from May 2019 to May 2020 in a North Indian tertiary care institute. Demographic, biochemical, and clinical data were collected. Seroprevalence was determined using QualisaTM HCV ELISA. Sixty seronegative and 30 seropositive samples underwent HCVc-Ag testing and HCV RT-PCR. Genotyping was carried out using AmpliSens® HCV-genotype PCR kit. The HCV core antigen assay was evaluated by taking HCV RT-PCR as the gold standard test. Of the 292 patients, 98 (30%) were seropositive for HCV, predominantly in the 40–59 age-group. Surgery and blood transfusion were significant risk factors. Co-infections included human immunodeficiency virus (HIV) (3.06%) and hepatitis B virus (HBV) (6.12%). Genotype 3a was the most prevalent. HCV core antigen assay showed 93.75% sensitivity, 93.10% specificity, 88.24% positive predictive value, 96.43% negative predictive value, and 93.33% accuracy. Hepatitis C virus core antigen is a dependable and economical substitute to HCV RT-PCR for diagnosing HCV infection. Regular screening in high-risk groups is essential for early detection and prevention. Rautela A, Raj N, Verma A, et al. Clinicoepidemiology and Diagnosis of Hepatitis C: Evaluating HCV Core Antigen Assay as a Diagnostic Tool in a Tertiary Care Teaching Hospital of North India. Euroasian J Hepato-Gastroenterol 2024;14(2):176–181.
- 27 December 2024
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 14 (2) , 176-181
Open AccessClinicoepidemiology and Diagnosis of Hepatitis C: Evaluating HCV Core Antigen Assay as a Diagnostic Tool in a Tertiary Care Teaching Hospital of North India
One of the main causes of primary hepatocellular carcinoma and chronic hepatitis is the hepatitis C virus (HCV), with significant variability in its genotypes affecting pathogenicity and treatment outcomes. In India, prevalence ranges from 0.5 to 1.5%, with certain regions showing higher rates. Diagnostic methods include serological and molecular assays, with the HCV core antigen (HCV cAg) assay emerging as a cost-effective substitute for HCV RT-PCR testing. This study enrolled 292 suspected hepatitis cases from May 2019 to May 2020 in a North Indian tertiary care institute. Demographic, biochemical, and clinical data were collected. Seroprevalence was determined using QualisaTM HCV ELISA. Sixty seronegative and 30 seropositive samples underwent HCVc-Ag testing and HCV RT-PCR. Genotyping was carried out using AmpliSens® HCV-genotype PCR kit. The HCV core antigen assay was evaluated by taking HCV RT-PCR as the gold standard test. Of the 292 patients, 98 (30%) were seropositive for HCV, predominantly in the 40–59 age-group. Surgery and blood transfusion were significant risk factors. Co-infections included human immunodeficiency virus (HIV) (3.06%) and hepatitis B virus (HBV) (6.12%). Genotype 3a was the most prevalent. HCV core antigen assay showed 93.75% sensitivity, 93.10% specificity, 88.24% positive predictive value, 96.43% negative predictive value, and 93.33% accuracy. Hepatitis C virus core antigen is a dependable and economical substitute to HCV RT-PCR for diagnosing HCV infection. Regular screening in high-risk groups is essential for early detection and prevention. Rautela A, Raj N, Verma A, et al. Clinicoepidemiology and Diagnosis of Hepatitis C: Evaluating HCV Core Antigen Assay as a Diagnostic Tool in a Tertiary Care Teaching Hospital of North India. Euroasian J Hepato-Gastroenterol 2024;14(2):176–181.
- Open Access
- 30 September 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 28 (10) , 908-911
Inconsistencies in the Indian Guidelines for the Prescription of Antibiotics for Critically Ill Patients
Raj N, Nath SS, Singh V, Agarwal J. Inconsistencies in the Indian Guidelines for the Prescription of Antibiotics for Critically Ill Patients. Indian J Crit Care Med 2024;28(10):908–911.
- 30 September 2024
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 28 (10) , 908-911
Open AccessInconsistencies in the Indian Guidelines for the Prescription of Antibiotics for Critically Ill Patients
Raj N, Nath SS, Singh V, Agarwal J. Inconsistencies in the Indian Guidelines for the Prescription of Antibiotics for Critically Ill Patients. Indian J Crit Care Med 2024;28(10):908–911.
- Open Access
- 12 June 2024
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 14 (1) , 60-64
Healthcare-associated Diarrhea due to Clostridioides difficile in Patients Attending a Tertiary Care Teaching Hospital of North India
Healthcare-associated diarrhea (HCAD) is diarrhea that develops at least after 3 days of hospitalization, with the most common infectious cause being Clostridioides difficile. Over the last decade, there has been a remarkable growth in the frequency and severity of C. difficile infection (CDI), making it one of the most prevalent healthcare-associated infections. This study aimed to analyze the prevalence and risk factors associated with CDI. A total of 107 patients with clinical suspicion of having HCAD were included in this study. Enzyme-linked fluorescent assay (ELFA) technique-based glutamate dehydrogenase (GDH) and toxin A/B assay were used as per the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) for diagnosing CDI. The details about associated comorbidities were retrieved from the hospital information system records. The presence of risk factors was noted. Risk factors associated with CDI were looked for. Out of the 107 stool samples received in the microbiology laboratory from patients with suspected HCAD eight (7.6%) samples were positive for CDI. The most frequent comorbidity observed in these patients was renal illness (acute or chronic kidney disease). In this study, a total of 7/8 cases were on multiple antibiotics most common being carbapenem. The 6-year prevalence of CDI observed in this study was found to be 7.6% risk factors, associated with CDI were kidney disease, diabetes mellitus, malignancy, and exposure to broad-spectrum antibiotics. Raj N, Agarwal J, Singh V, et al. Healthcare-associated Diarrhea due to Clostridioides difficile in Patients Attending a Tertiary Care Teaching Hospital of North India. Euroasian J Hepato-Gastroenterol 2024;14(1):60–64.
- 12 June 2024
- Published by Jaypee Brothers Medical Publishing in Euroasian Journal of Hepato-Gastroenterology
- Vol. 14 (1) , 60-64
Open AccessHealthcare-associated Diarrhea due to Clostridioides difficile in Patients Attending a Tertiary Care Teaching Hospital of North India
Healthcare-associated diarrhea (HCAD) is diarrhea that develops at least after 3 days of hospitalization, with the most common infectious cause being Clostridioides difficile. Over the last decade, there has been a remarkable growth in the frequency and severity of C. difficile infection (CDI), making it one of the most prevalent healthcare-associated infections. This study aimed to analyze the prevalence and risk factors associated with CDI. A total of 107 patients with clinical suspicion of having HCAD were included in this study. Enzyme-linked fluorescent assay (ELFA) technique-based glutamate dehydrogenase (GDH) and toxin A/B assay were used as per the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) for diagnosing CDI. The details about associated comorbidities were retrieved from the hospital information system records. The presence of risk factors was noted. Risk factors associated with CDI were looked for. Out of the 107 stool samples received in the microbiology laboratory from patients with suspected HCAD eight (7.6%) samples were positive for CDI. The most frequent comorbidity observed in these patients was renal illness (acute or chronic kidney disease). In this study, a total of 7/8 cases were on multiple antibiotics most common being carbapenem. The 6-year prevalence of CDI observed in this study was found to be 7.6% risk factors, associated with CDI were kidney disease, diabetes mellitus, malignancy, and exposure to broad-spectrum antibiotics. Raj N, Agarwal J, Singh V, et al. Healthcare-associated Diarrhea due to Clostridioides difficile in Patients Attending a Tertiary Care Teaching Hospital of North India. Euroasian J Hepato-Gastroenterol 2024;14(1):60–64.